The Diabetic Nephropathy Market is anticipated to expand significantly, with its valuation rising from USD 2.33 billion in 2023 to an estimated USD 3.72 billion by 2031, at a CAGR of 6.04% during the forecast period from 2024 to 2031. This growth is driven by the increasing prevalence of diabetes, advancements in therapeutics, and a rising focus on early diagnosis and treatment of diabetic kidne..
